Computational Tasks in Medical Nanorobotics

Bio-Inspired and Nanoscale Integrated Computing

Volumn , Issue , 2009, Pages 391-428

  Freitas, Robert A ^a  

^a Institute for Molecular Manufacturing   (United States)

Author keywords

Computational tasks in medical nanorobotics; Exemplar medical nanorobot designs; Functions requiring onboard computation

Indexed keywords

EID: 84860549104     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470429983.ch15     Document Type: Chapter

References (84)

1. R. A. Freitas, Jr. Nanomedicine, Volume I: Basic Capabilities. Georgetown, TX: Landes Bioscience, 1999; http://www.nanomedicine.com/NMI.htm; Chapter 4, (b) 9.3, (c) Chapter 6, (d) 10.2, (e) 10.3, (f) 3.4.2, (g) 6.3.4, (h) 4.2.1, (i) 4.6, (j) 4.2, (k) 4.5, (m) 7.2.2, (n) 10.3.6, (o) 4.5.4, (p) 6.3.2, (q) 6.4.1, (r) 7.2.5.3, (s) 6.4.3, (t) 7.2.5.4, (u) 6.3.4.4, (v) 6.3.4.5, (w) 6.3.4.2, (x) 6.4.3.4, (y) 10.2.1, (z) 9.5.1, (aa) 7.4.6, (ab) 10.4.2.4.2, (ac) 8.5.2.2, (ad) 9.3.1.4, (ae) 9.3.5.1, (af) 7.2.6, (ag) 8.5.2.1, (ah) 8.2.1.1, (ai) 9.4.1.4, (aj) 3.2, (ak) 10.5.4, (am) 7.4.5.2, (an) Chapter 8, (ao) 9.4.4.1, (ap) 9.4.4, (aq) 9.4.5, (ar) 9.4.5.3, (as) 9.4.4.2, (at) 9.4.2.5.1, (au) 8.3.3, (av) 4.7, (aw) 4.9.2, (ax) 4.9.2.4, (ay) 4.2.8, (az) 8.5.2, (ba) 4.9.1, (bb) 4.9.3, (bc) 4.9.4, (bd) 4.9.5, (be) Chapter 5, (bf) 5.4, (bg) 5.3.6, (bh) Chapter 7, (bi) 9.4, (bj) 9.5, (bk) 10.1, (bm) 7.3, (bn) 9.4.7, (bo) 8.4.1.3, (bp) 9.5.3.6, (bq) 7.4.6.7.
2. R. A. Freitas, Jr. Nanomedicine, Volume IIA: Biocompatibility. Georgetown, TX: Landes Bioscience, 2003; http://www.nanomedicine.com/NMIIA.htm; (a) 15.6.2, (b) 15.4.3.1, (c) 15.4.3.2.3, (d) 15.4.3.6, (e) 15.4.2.3, (f) 15.4.2, (g) 15.4.3.6.1, (h) 15.4.3.6.4, (i) 15.2.5, (j) 15.5.2.2, (k) 15.2.2.4, (m) 15.4.3.4.
3. R. A. Freitas, Jr. Current status of nanomedicine and medical nanorobotics (Invited Survey). Journal of Computational and Theoretical Nanoscience, 2: pp 1-25, Mar 2005; http://www.nanomedicine.com/Papers/NMRevMar05.pdf.
4. R. A. Freitas, Jr. Exploratory design in medical nanotechnology: A mechanical artificial red cell. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, 26: pp 411-430, 1998; http://www.foresight.org/Nanomedicine/Respirocytes.html.
5. R. A. Freitas, Jr. Microbivores: Artificial mechanical phagocytes using digest and discharge protocol. Journal of Evolution and Technology, 14: pp 1-52, Apr 2005; http:// www.jetpress.org/volume14/freitas.html.
6. R. A. Freitas, Jr. Clottocytes: Artificial Mechanical Platelets. Foresight Update No. 41: pp 9-11, June 30, 2000; http://www.imm.org/Reports/Rep018.html.
7. R. A. Freitas, Jr. The ideal gene delivery vector: chromallocytes, cell repair nanorobots for chromosome replacement therapy. Journal of Evolution and Technology, 16: pp. 1-97, June 2007; http://jetpress.org/v16/freitas.pdf.
8. R. A. Freitas, Jr. Christopher J. Phoenix. Vasculoid: a personal nanomedical appliance to replace human blood. Journal of Evolution and Technology, 11: pp 1-139, Apr 2002; http://www.jetpress.org/volume11/vasculoid.pdf.
9. R. A. Freitas, Jr. Nanodentistry. The Journal of the American Dental Association, 131: pp 1559-1566, Nov 2000; http://www.rfreitas.com/Nano/Nanodentistry.htm.
10. R. A. Freitas Jr. Pharmacytes: An ideal vehicle for targeted drug delivery. Journal of Nanoscience and Nanotechnology, 6: pp 2769-2775, Sep-Oct 2006; http://www.nanomedicine.com/Papers/JNNPharm06.pdf.
11. Nanofactory Collaboration website. Accessed Jan 2007. http://www.Molecular Assembler.com/Nanofactory.
12. K. E. Drexler. Nanosystems: Molecular Machinery, Manufacturing, and Computation. New York: Wiley, 1992; (a) Chapter 10, (b) Chapter 11, (c) 13.4, (d) Chapter 12, (e) 16.3.2, (f) 12.4, (g) 6.7.2.
13. R. A. Freitas Jr. and R. C. Merkle. Kinematic Self-Replicating Machines. Georgetown, TX: Landes Bioscience, 2004; http://www.molecularassembler.com/KSRM.htm.
14. K. Ishiyama, M. Sendoh, and K. I. Arai. Magnetic micromachines for medical applications. Journal of Magnetism and Magnetic Materials, 242-245: pp 1163-1165, 2002.
15. D. D. Chrusch, B. W. Podaima, and R. Gordon. Cytobots: intracellular robotic micromanipulators. In: W. Kinsner, A. Sebak, editors. Conference Proceedings, 2002 IEEE Canadian Conference on Electrical and Computer Engineering. Winnipeg, Canada: 2002.
16. J. B. Mathieu, S. Martel, L. Yahia, G. Soulez, and G. Beaudoin. MRI systems as a mean of propulsion for a microdevice in blood vessels. Biomedical Materials and Engineering, 15: pp 367, 2005.
17. K. B. Yesin, P. Exner, K. Vollmers, and B. J. Nelson. Biomedical micro-robotic system. 8th International Conference on Medical Image Computing and Computer Assisted Intervention (MICCAI 2005), Palm Springs, California, Oct 26-29, 2005; www.miccai2005.org; p 819.
18. Micro-robots take off as ARC announces funding. Monash University, Oct 11, 2006http://www.monash.edu.au/news/newsline/story/1038.
19. Committee to Review the National Nanotechnology Initiative, National Materials Advisory Board (NMAB), National Research Council (NRC). A Matter of Size: Triennial Review of the National Nanotechnology Initiative. Washington DC: The National Academies Press, 2006; http://www.nap.edu/catalog/11752.html#toc.
20. R. C. Merkle and R. A. Freitas Jr. Theoretical analysis of a carbon-carbon dimer placement tool for diamond mechanosynthesis. Journal of Nanoscience and Nanotechnology, 3: pp 319-324, Aug 2003; http://www.rfreitas.com/Nano/JNNDimerTool.pdf.
21. R. A. Freitas Jr., inventor. A simple tool for positional diamond mechanosynthesis, and its method of manufacture. U.S. Provisional Patent Application No. 60/543,802, filed Feb 11, 2004; U.S. Patent Pending, Feb 11, 2005; http://www.MolecularAssembler.com/ Papers/DMSToolbuildProvPat.htm.
22. J. Peng, R. A. Freitas Jr., R. C. Merkle, J. R. Von Ehr, J. N. Randall, and G. D. Skidmore. Theoretical analysis of diamond mechanosynthesis. Part III. Positional C2 deposition on diamond C(110) surface using Si/Ge/Sn-based dimer placement tools. Journal of Computational and Theoretical Nanoscience, 3: pp 28-41, Feb 2006; http://www.MolecularAssembler.com/Papers/JCTNPengFeb06.pdf.
23. B. Temelso, C. D. Sherrill, R. C.Merkle, and R. A. Freitas Jr. High-level ab initio studies of hydrogen abstraction from prototype hydrocarbon systems. Journal of Physical Chemistry A, 110: pp 11160-11173, Sep 28, 2006; http://www.MolecularAssembler.com/Papers/TemelsoHAbst.pdf.
24. H. J. Lee and W. Ho. Single bond formation and characterization with a scanning tunneling microscope. Science, 286: pp 1719-1722, 1999; http://www.physics.uci.edu/%7Ewilsonho/stm-iets.html.
25. N. Oyabu, O. Custance, I. Yi, Y. Sugawara, and S. Morita. Mechanical vertical manipulation of selected single atoms by soft nanoindentation using near contact atomic force microscopy. Physical Review Letters, 90: p 176102, May 2, 2003; http://link.aps.org/abstract/PRL/v90/e176102.
26. P. Vettiger, G. Cross, M. Despont, U. Drechsler, U. Duerig, B. Gotsmann, W. Haeberle, M. Lantz, H. Rothuizen, R. Stutz, and G. Binnig. The millipede: nanotechnology entering data storage. IEEE Transactions on Nanotechnology, 1: pp 39-55, Mar 2002.
27. D. Bullen, S. Chung, X. Wang, J. Zou, C. Liu, and C. Mirkin. Development of parallel dip pen nanolithography probe arrays for high throughput nanolithography. Symposium LL: Rapid Prototyping Technologies, Materials Research Society Fall Meeting; Dec 2-6, 2002; Boston, Proceedings of the MRS, Vol. 758, 2002; http://mass.micro.uiuc.edu/publications/papers/84.pdf.
28. Microcantilever Arrays. Protiveris Corp., 2003; http://www.protiveris.com/cantilever_tech/microcantileverarrays.html.
29. S. Martel and I. Hunter. Nanofactories based on a fleet of scientific instruments configured as miniature autonomous robots. Proceedings of the 3rd International Workshop on Microfactories; Sep 16-18, 2002; Minneapolis, pp 97-100, 2002.
30. G. R. Ter Haar. Biological effects of ultrasound in clinical applications. In: K. S. Suslick, editor. Ultrasound: Its Chemical, Physical and Biological Effects. New York: VCH Publishers, 1988.
31. E. Ayers. An automatic chemical plant. Scientific American, 187: pp 82-88; 1952.
32. H. D. Luke. Automation for Productivity. New York: Wiley, 1972.
33. C. Bennett. The thermodynamics of computation-A review. International Journal of Theoretical Physics, 21: pp 905-940, 1981.
34. R. C. Merkle. Reversible electronic logic using switches. Nanotechnology, 4: pp 21-40, 1993.
35. J. S. Hall. Nanocomputers and reversible logic. Nanotechnology, 5: pp 157-167, 1994.
36. W. H. Weihe, editor. Physiological Effects of High Altitude. New York: Macmillan, 1964
37. L. Jia, C. Bonaventura, J. Bonaventura, and J. S. Stamler. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature, 380: pp 221-226, 1996.
38. H. L. Goldsmith and V. T. Turitto. Rheological aspects of thrombosis and haemostasis: basic principles and applications. Journal of Thrombosis and Haemostasis, 55: pp 415-435, 1986.
39. M. H. Smit and A. E. G. Cass. Cyanide detection using a substrate-regenerating, peroxidase-based biosensor. Analytical Chemistry, 62: pp 2429-2436, 2006.
40. A. J. Erslev. In Vitro production of erythropoietin by kidneys perfused with a serum-free solution. Blood, 44: pp 77-85, 1974.
41. E. F. Fincher, L. Johannsen, L. Kapas, S. Takahashi and J. M. Krueger. Microglia digest staphylococcus aureus into low molecular weight biologically active compounds. American Journal of Physiology, 271: pp R149-R156, July 1996.
42. C. Strange and S. A. Sahn. The definitions and epidemiology of pleural space infection. Seminars in Respiratory and Critical Care Medicine, 14: pp 3-8, Mar 1999.
43. L. Carreno Perez. Septic arthritis. Baillieres Best Practice and Research Clinical Rheumatology, 13: pp 37-58, Mar 1999.
44. J. W. Costerton, P. S. Stewart, and E. P. Greenberg. Bacterial biofilms: a common cause of persistent infections. Science, 284: pp 1318-1322, May 21, 1999.
45. D. Goldin. Remarks at the 15th Annual NASA Continual Improvement and Reinvention Conference. Apr 27, 2000; http://rk.gsfc.nasa.gov/richcontent/Speeches/goldin_remarks_5ps.pdf.
46. N. Leveson. Information and Computer Science Department, University of California, Irvine. Viking Lander. The Risks Digest 3: Oct 1, 1986; http://128,240.150.127/Risks/3.72.html#subj1.
47. P. Marks. Dependence day. New Scientist: July 31, 1999; http://www.newscientist.com/article/mg16321971.000-dependence-day.html.
48. Ada Information Clearinghouse. Ada in Airbus 340 Flight Warning System. ITT Research Institute, 1994; http://www.adahome.com/Ammo/Success/aerofws.html.
49. H. Lin. The development of software for ballistic-missile defense. Scientifc American, 253: p 52, Dec 1985.
50. V. Cortellessa, B. Cukic, D. Del Gobbo, A. Mili, M. Napolitano, M. Shereshevsky, and H. Sandhu. Certifying adaptive flight control software. Proceedings of ISACC 2000: The Software Risk Management Conference. Reston, VA, Sep 2000; http://www.isacc.com/presentations/3c-bc.pdf.
51. D. E. Van Epps and B. R. Andersen. Streptolysin O inhibition of neutrophil chemotaxis and mobility: nonimmune phenomenon with species specificity. Infection and Immunology, 9: pp 27-33, Jan 1974.
52. A. Odegaard and J. Lamvik. The effect of phenylbutazone and chloramphenicol on phagocytosis of radiolabeled candida albicans by human monocytes cultured in vitro. Acta Pathologica et Microbiologica Scandinavica. Section C, Immunology, 84: pp 37-44, Feb 1976.
53. R. Kumar, J. E. Ansell, R. T. Canoso, and D. Deykin. Clinical trial of a new bleedingtime device. American Journal of Clinical Pathology, 70: pp 642-645, Oct 1978.
54. L. R. Hertzendorf, L. Stehling, A. S. Kurec, and F. R. Davey. Comparison of bleeding times performed on the arm and the leg. American Journal of Clinical Pathology, 87: pp 393-396, Mar 1987.
55. S. E. Lind. Chapter 33. The Hemostatic System In: R. I. Handin, T. P. Stossel, and S. E. Lux, editors. Blood: Principles and Practice of Hematology. Philadelphia: Lippincott, 1995 pp 949-972.
56. L. Ardekian, R. Gaspar, M. Peled, B. Brener, and D. Laufer. Does low-dose aspirin therapy complicate oral surgical procedures? Journal of the American Dental Association, 131: pp 331-335, Mar 2000.
57. R. L. Bick, B. Arun, and E. P. Frenkel. Disseminated intravascular coagulation. Clinical and pathophysiological mechanisms and manifestations. Haemostasis, 29: pp 111-134, 1999.
58. T. E. Warkentin. Heparin-induced thrombocytopenia: a ten-year retrospective. Annual Review of Medicine, 50: pp 129-147, 1999.
59. D. B. Brieger, K. H. Mak, K. Kottke-Marchant, and E. J. Topol. Heparin-induced thrombocytopenia. Journal of the American College of Cardiology, 31: pp 1449-1459, June 1998.
60. J. R. Sklaroff. Redundancy management technique for space shuttle computers. IBM Journal of Research and Development, 20: pp 20-28, Jan 1976; http://www.research.ibm.com/journal/rd/201/ibmrd2001E.pdf.
61. M. Malek. Survivable algorithms and redundancy management in NASA's distributed computing systems. Final Technical Report, NAS 1.26:189827, NASA/NTIS, 1992.
62. G. Huszerl and I. Majzik. Modeling and analysis of redundancy management in distributed object-oriented systems by using UML statecharts. 27th Euromicro Conference, 2001: A Net Odyssey (Euromicro'01): p 200, 2001.
63. C. Fishman. They write the right stuff. Fast Company, no. 6: p 95, Dec 1996; http://www.fastcompany.com/magazine/06/writestuff.html.
64. M. A. Coppess, J. M. Miller, D. P. Zipes, and W. J. Groh. Software error resulting in malfunction of an implantable cardioverter defibrillator. Journal Cardiovascular Electrophysiology, 10: pp 871-873, June 1999.
65. T. P. Ozahowski, M. L. Greenberg, P. Mock, P. T. Holzberger, B. Gerling, C. Zalinger, and C. Perry. Implantable cardioverter defibrillator clinic casualties: inadvertent reprogramming during routine implantable cardioverter defibrillator follow-up. Pacing and Clinical Electrophysiology, pp 1524-1525, Oct 19, 1996.
66. E. Ruoslahti. Stretching is good for a cell. Science, 276: pp 1345-1346, May 30, 1997.
67. C. S. Chen, M. Mrksich, S. Huang, G. M. Whitesides, and D. E. Ingber. Geometric control of cell life and death. Science, 276: pp 1425-1428, May 30, 1997.
68. A. Grakoui, S. K. Bromley, C. Sumen, M. M. Davis, A. S. Shaw, P. M. Allen, and M. L. Dustin. The immunological synapse: a molecular machine controlling T cell activation. Science, 285: pp 221-227, July 9, 1999.
69. D. A. Karnofsky and J. H. Burchenal. The clinical evaluation of chemotherapeutic agents in cancer In: C. M. MacLeod, editor. Evaluation of Chemotherapeutic Agents. New York: Columbia University Press, 1949, p 196.
70. D. F. Swaab and M. A. Hofman. Sexual differentiation of the human hypothalamus in relation to gender and sexual orientation. Trends in Neurosciences, 18: pp 264-270, June 1995.
71. W. H. James. Biological and psychosocial determinants of male and female human sexual orientation. Journal of Biosocial Science, 37: pp 555-567, Sep 2005.
72. M. J. Sergeant, T. E. Dickins, M. N. Davies, and M. D. Griffiths. Women's hedonic ratings of body odor of heterosexual and homosexual men. Archives of Sexual behavior: Dec 22 2006.
73. N. Sharon and H. Lis. Carbohydrates in Cell Recognition. Scientific American, 268: pp 82-89, Jan 1993.
74. R. A. Laine. A calculation of all possible oligosaccharide isomers, both branched and linear yields 1.05x1012 structures for a reducing hexasaccharide: the isomer barrier to development of single-method saccharide sequencing or synthesis systems. Glycobiology, 4: pp 1-9, 1994.
75. T. W. Heeter, inventor. Method for verifying human identity during electronic sale transactions. United States Patent 5,878,155, Mar 2 1999; http://patents.uspto.gov/cgi-bin/ifetch4?ENG+PATBIB-ALL+0+967198+0+7+25907+OF+1+1+1+PN%2f5878155.
76. D. Dorner. The Logic of Failure, Metropolitan Books. (English translation). New York: Henry Holt, 1996.
77. A. Cavalcanti and R. A. Freitas Jr. Autonomous multi-robot sensor-based cooperation for nanomedicine. International Journal of Nonlinear Sciences and Numerical Simulation, 3: pp 743-746, Aug 2002; http://lipari.usc.edu/Bpal/cs5xx/Cavalcanti02.pdf.
78. M. S. Miller and K. E. Drexler. Markets and computation: agoric open systems. In: B. A. Huberman, editor. The Ecology of Computation. Amsterdam: Elsevier, 1988; http://www.agorics.com/Library/agoricpapers/aos/aos.0.html.
79. O. Guenther, T. Hogg, and B. A. Huberman. Market organizations for controlling smart matter In: R. Conte, R. Hegselmann, and P. Terna, editors. Simulating Social Phenomena, Lecture Notes in Economics and Mathematical Systems. Berlin: Springer, 1997, pp 241-257.
80. J. S. Hall, L. Steinberg, and B. D. Davison. Combining agoric and genetic methods in stochastic design. Nanotechnology, 9: pp 274-284, Sep 1998; http://www.cs.rutgers.edu/Bdavison/pubs/chsmith/chsmith.html.
81. T. Toth-Fejel. Agents, assemblers, and ANTS: scheduling assembly with market and biological software mechanisms. Nanotechnology, 11: pp 133-137, June 2000; http://www.erim.org/cec/papers/NanoAgents.pdf.
82. E. Bonabeau, S. Guerin, D. Snyers, P. Kuntz, and G. Theraulaz. Three-dimensional architectures grown by simple 'stigmergic' agents. BioSystems, 56: pp 13-32, 2000.
83. E. Bonabeau, M. Dorigo, and G. Theraulaz. Swarm Intelligence: From Natural to Artificial Systems. Santa Fe Institute Sciences of Complexity Series. New York: Oxford University Press, 1999.
84. G. Theraulaz and E. Bonabeau. Modeling the collective building of complex architectures in social insects with lattice swarms. Journal of Theoretical Biology, 177: pp 381-400, 1995.